Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) EBITDA Margin: 2016-2018

Historic EBITDA Margin for ENDRA Life Sciences (NDRA) over the last 2 years, with Mar 2018 value amounting to -45,960.77%.

  • ENDRA Life Sciences' EBITDA Margin was N/A to -45,960.77% in Q1 2018 from the same period last year, while for Mar 2018 it was -1,984.92%, marking a year-over-year change of. This contributed to the annual value of -9,971.19% for FY2024, which is 768648.00% down from last year.
  • According to the latest figures from Q1 2018, ENDRA Life Sciences' EBITDA Margin is -45,960.77%, which was down 37.09% from -33,526.58% recorded in Q4 2017.
  • Over the past 5 years, ENDRA Life Sciences' EBITDA Margin peaked at 249,652.53% during Q2 2016, and registered a low of -45,960.77% during Q1 2018.
  • In the last 3 years, ENDRA Life Sciences' EBITDA Margin had a median value of -317.40% in 2017 and averaged 24,016.98%.
  • Data for ENDRA Life Sciences' EBITDA Margin shows a maximum YoY slumped of 25,148,188bps (in 2017) over the last 5 years.
  • Quarterly analysis of 3 years shows ENDRA Life Sciences' EBITDA Margin stood at -61.85% in 2016, then crashed by 3,346,474bps to -33,526.58% in 2017, then reached -45,960.77% in 2018.
  • Its EBITDA Margin was -45,960.77% in Q1 2018, compared to -33,526.58% in Q4 2017 and -317.40% in Q3 2017.